(Q43543562)

24 November 2017

Inflammation-sensitive proteins and risk of atrial fibrillation: a population-based cohort study (English)

1 reference

24 November 2017

1 reference

Gunnar Engström

5

0 references

Olle Melander

series ordinal

3

object named as

Olle Melander

1 reference

24 November 2017

2

J Gustav Smith

1 reference

24 November 2017

1

Samuel Adamsson Eryd

1 reference

24 November 2017

Bo Hedblad

4

1 reference

24 November 2017

19 March 2011

1 reference

European Journal of Epidemiology

24 November 2017

1 reference

24 November 2017

26

1 reference

24 November 2017

449-455

1 reference

24 November 2017

6

1 reference

https://scigraph.springernature.com/pub.10.1007/s10654-011-9565-6

24 November 2017

0 references

cites work

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Secular trends in incidence of atrial fibrillation in Olmsted County, Minnesota, 1980 to 2000, and implications on the projections for future prevalence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Current perceptions of the epidemiology of atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Lifetime risk for development of atrial fibrillation: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Incidence of and risk factors for atrial fibrillation in older adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Atrial fibrillation in the Malmö Diet and Cancer study: a study of occurrence, risk factors and diagnostic validity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Effects of cholesterol and inflammation-sensitive plasma proteins on incidence of myocardial infarction and stroke in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Circulating inflammatory markers and risks of cardiovascular and non-cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Role of inflammation in initiation and perpetuation of atrial fibrillation: a systematic review of the published data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inflammation as a risk factor for atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Relation of multiple inflammatory biomarkers to incident atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inflammation-sensitive plasma proteins, diabetes, and mortality and incidence of myocardial infarction and stroke: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Indicators of alcohol consumption: comparisons between a questionnaire (Mm-MAST), interviews and serum gamma-glutamyl transferase (GGT) in a health survey of middle-aged males.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Complement C3 is a risk factor for the development of diabetes: a population-based cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inter-relationships of atrial fibrillation and atrial flutter mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Intact human ceruloplasmin oxidatively modifies low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

N-acetylcysteine for the prevention of postoperative atrial fibrillation: a prospective, randomized, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Oxidative stress markers are associated with persistent atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inflammation: a possible pathogenic link to atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Histological substrate of atrial biopsies in patients with lone atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Blood pressure increase and incidence of hypertension in relation to inflammation-sensitive plasma proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Inflammation-sensitive plasma proteins are associated with future weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Secular trends in the prevalence of atrial fibrillation: The Framingham study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Does Elevated C-Reactive Protein Increase Atrial Fibrillation Risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10654-011-9565-6

Long-term high copper intake: effects on indexes of copper status, antioxidant status, and immune function in young men.

21 January 2018

1 reference

12 December 2020

Fibrin(ogen) in cardiovascular disease: an update

1 reference

12 December 2020

Tissue factor expression in atrial endothelia associated with nonvalvular atrial fibrillation: possible involvement in intracardiac thrombogenesis

1 reference

12 December 2020

Epidemiology of atrial fibrillation

1 reference

12 December 2020

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC).

1 reference

12 December 2020

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

1 reference

12 December 2020

Effects of C-reactive protein and the third and fourth components of complement (C3 and C4) on incidence of atrial fibrillation

1 reference

12 December 2020

C-Reactive protein in lone atrial fibrillation

1 reference

12 December 2020

1 reference

12 December 2020

Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis.

1 reference

12 December 2020

10.1007/S10654-011-9565-6

Identifiers

DOI

1 reference

PubMed ID

21424216

Dimensions Publication ID

24 November 2017

0 references

1 reference

PubMed ID

21424216